APR 22, 2017 1:59 PM PDT

Bacteria-infecting Viruses Inspire Creation of Hybrid Antibodies

WRITTEN BY: Kara Marker

It seems humans share a common enemy with some viruses: bacteria. Viruses invade bacterial cells with generally the same agenda that bacteria have when invading the human body - wipe out host cells and multiply. Borrowing a page from the playbook of bacteria-infecting viruses, called bacteriophages, could help researchers enhance the human immune system to better attack the toughest bacterial species.

Summoned by lysibody molecules, large immune cells called macrophages (red) engulf Staphylococcus aureus bacteria (green).

Bacteriophages have unique molecules that recognize and target specific carbohydrate molecules on the cell surface of bacteria, but the human immune system is ignorant of these molecules. “We have co-opted these molecules, and we've put them to work helping the human immune system fight off microbial pathogens," explained lab head Vincent A. Fischetti.

These viruses then use lysins, dubbed “molecular snippers” by Fischetti and his team, to poke holes in the cell surface of the bacterium after latching on to cell surface carbohydrate molecules. Antibodies produced by the human immune system are similar in structure and practice a similar method, but alas they are unable to identify bacterial carbohydrate molecules.

"Both antibodies and lysins have two discrete components,” explained research associate Assaf Raz. “They both have a part that binds their respective target, but whereas the second component of lysins cuts the bacterial cell wall, in antibodies it coordinates an immune response.”

In their study, researchers replaced the parts of human antibodies where their anti-bacterial approach fell short with the advantages of lysins, a switch made possible thanks to the two components sharing similar structure.

"This made it possible for us to mix and match, combining the viral piece responsible for latching onto a carbohydrate with the part of the antibody that tells immune cells how to respond,” Raz said.

The new “best of both worlds” antibody they created was labeled a lysibody, and the researchers ventured next to test lysibodies in a mice model of methicillin-resistant Staphylococcus aureus, commonly known as MRSA, a bacterial species infamous for being resistant to the harshest antibiotic treatments, earning the name of “superbug.”

The mice studies were successful; the experimental lysibodies identified and targeted carbohydrates on the cell surface of MRSA bacteria as well as other strains of S. aureus and even other types of bacteria.

“Based on our results, it may be possible to use not just lysins, but any molecule with a high affinity toward a target on any pathogen -- be it virus, parasite, or fungus -- to create hybrid antibodies," Fischetti claimed. "This approach could make it possible to develop a new class of immune boosting therapies for infectious diseases."

The present study was published in the journal Proceedings for the National Academy of Sciences.

Source: The Rockefeller University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 01, 2021
Microbiology
A Potential Leptospirosis Vaccine is Created
FEB 01, 2021
A Potential Leptospirosis Vaccine is Created
Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause dise ...
MAR 07, 2021
Genetics & Genomics
Tuberculosis Influenced the Human Genome
MAR 07, 2021
Tuberculosis Influenced the Human Genome
Throughout human history, our species has come into contact with both harmless and infectious microbes that have changed ...
APR 19, 2021
Cell & Molecular Biology
Insight Into the Molecular Basis of Rheumatoid Arthritis
APR 19, 2021
Insight Into the Molecular Basis of Rheumatoid Arthritis
New research has shown how variants in an immune gene can lead to a high risk of developing the autoimmune disorder rheu ...
MAY 12, 2021
Immunology
Illuminating the COVID-19 Disease Profile Puzzle
MAY 12, 2021
Illuminating the COVID-19 Disease Profile Puzzle
Teams of science experts from numerous disciplines have been collecting data on SARS-CoV-2 for over a year to understand ...
MAY 20, 2021
Immunology
Why Delaying the 2nd COVID Shot is Paying Off for Some
MAY 20, 2021
Why Delaying the 2nd COVID Shot is Paying Off for Some
A new study indicates that delaying the second “booster” dose of the Pfizer-BioNTech COVID vaccine (to 11-12 ...
JUN 15, 2021
Clinical & Molecular DX
An Early Warning System for Type 1 Diabetes in Children
JUN 15, 2021
An Early Warning System for Type 1 Diabetes in Children
In type 1 diabetes, or T1D, the body’s own immune system mistakenly launches an aggressive attack on insulin-produ ...
Loading Comments...